Review of lipid and lipoprotein(a) abnormalities in childhood arterial ischemic stroke

International Journal of Stroke

Volumn 9, Issue 1, 2014, Pages 79-87

  Sultan, Sally M ^a   Schupf, Nicole ^b,c   Dowling, Michael M ^d   Deveber, Gabrielle A ^e   Kirton, Adam ^f   Elkind, Mitchell S V ^a,c  

^a NEUROLOGICAL INSTITUTE   (United States)

^b Vagelos College of Physicians and Surgeons   (United States)

^c Department of Medicine   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

Atherosclerosis; Childhood stroke; Cholesterol; Lipid; Lipoprotein(a); Risk factor

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DYSLIPIDEMIA; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ATHEROSCLEROSIS; CHILDHOOD STROKE; CHOLESTEROL; LIPID; LIPOPROTEIN(A); RISK FACTOR;

CHILD; DYSLIPIDEMIAS; HUMANS; LIPIDS; LIPOPROTEIN(A); RISK FACTORS; STROKE;

EID: 84890856783     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12136     Document Type: Review

References (74)

1. Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003; 53:167-173.
2. Dlamini N, Freeman JL, Mackay MT etal. Intracranial dissection mimicking transient cerebral arteriopathy in childhood arterial ischemic stroke. J Child Neurol 2011; 26:1203-1206.
3. Amlie-Lefond C, Bernard TJ, Sebire G etal. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation 2009; 119:1417-1423.
4. Fullerton HJ, Elkind MS, Barkovich AJ etal. The vascular effects of infection in Pediatric Stroke (VIPS) Study. J Child Neurol 2011; 26:1101-1110.
5. Mackay MT, Wiznitzer M, Benedict SL, Lee KJ, Deveber GA, Ganesan V. Arterial ischemic stroke risk factors: the International Pediatric Stroke Study. Ann Neurol 2011; 69:130-140.
6. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 2001; 104:2815-2819.
7. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338:1650-1656.
8. McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological determinants of atherosclerosis in youth. Arterioscler Thromb Vasc Biol 1997; 17:95-106.
9. Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 1977; 46:897-930.
10. Schwartz CJ, Mitchell JR. The morphology, terminology and pathogenesis of arterial plaques. Postgrad Med J 1962; 38:25-34.
11. Kritchevsky D, Tepper SA, Kim HK, Moses DE, Story JA. Experimental atherosclerosis in rabbits fed cholesterol-free diets. 4. Investigation into the source of cholesteremia. Exp Mol Pathol 1975; 22:11-19.
12. Minick CR, Murphy GE, Campbell WG Jr. Experimental induction of athero-arteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet. I. Effect of repeated injections of horse serum in rabbits fed a dietary cholesterol supplement. J Exp Med 1966; 124:635-652.
13. Van Winkle M, Levy L. Effect of removal of cholesterol diet upon serum sickness-cholesterol-induced atherosclerosis. J Exp Med 1968; 128:497-515.
14. Tauber JP, Cheng J, Gospodarowicz D. Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells. J Clin Invest 1980; 66:696-708.
15. Mills GL, Taylaur CE. The distribution and composition of serum lipoproteins in eighteen animals. Comp Biochem Physiol B 1971; 40:489-501.
16. Erqou S, Kaptoge S, Perry PL etal. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009; 302:412-423.
17. Kenet G, Lutkhoff LK, Albisetti M etal. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation 2010; 121:1838-1847.
18. Utermann G. The mysteries of lipoprotein(a). Science 1989; 246:904-910.
19. Scanu AM, Fless GM. Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest 1990; 85:1709-1715.
20. Marcovina SM, Koschinsky ML. Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside. Curr Opin Lipidol 2003; 14:361-366.
21. Chunsheng L, Cai L, Aimin L, Rongbin Z, Xiulan G. A correlative study on serum Lp(a) in patients of cerebral infarction with that in their children. Chin Med Sci J 1999; 14:232.
22. Gonzalez-Requejo A, Sanchez-Bayle M, Ruiz-Jarabo C etal. Lipoprotein(a) and cardiovascular risk factors in a cohort of 6-year-old children. The Rivas-Vaciamadrid Study. Eur J Pediatr 2003; 162:572-575.
23. Strater R, Becker S, von Eckardstein A etal. Prospective assessment of risk factors for recurrent stroke during childhood - a 5-year follow-up study. Lancet 2002; 360:1540-1545.
24. van den Hurk K, van Dommelen P, van Buuren S, Verkerk PH, Hirasing RA. Prevalence of overweight and obesity in the Netherlands in 2003 compared to 1980 and 1997. Arch Dis Child 2007; 92:992-995.
25. Bundred P, Kitchiner D, Buchan I. Prevalence of overweight and obese children between 1989 and 1998: population based series of cross sectional studies. BMJ 2001; 322:326-328.
26. Parrino C, Rossetti P, Baratta R etal. Secular trends in the prevalence of overweight and obesity in Sicilian schoolchildren aged 11-13 years during the last decade. PLoS ONE 2012; 7:e34551.
27. Martinson ML, Teitler JO, Reichman NE. Health across the life span in the United States and England. Am J Epidemiol 2011; 173:858-865.
28. George MG, Tong X, Kuklina EV, Labarthe DR. Trends in stroke hospitalizations and associated risk factors among children and young adults, 1995-2008. Ann Neurol 2011; 70:713-721.
29. Gandhi SK, McKinney JS, Sedjro JE, Cosgrove NM, Cabrera J, Kostis JB. Temporal trends in incidence and long-term case fatality of stroke among children from 1994 to 2007. Neurology 2012; 78:1923-1929.
30. Obama MT, Dongmo L, Nkemayim C, Mbede J, Hagbe P. Stroke in children in Yaounde, Cameroon. Indian Pediatr 1994; 31:791-795.
31. Dusser A, Goutieres F, Aicardi J. Ischemic strokes in children. J Child Neurol 1986; 1:131-136.
32. Janaki S, Baruah JK, Jayaram SR, Saxena VK, Sharma SH, Gulati MS. Stoke in the young: a four-year study, 1968 to 1972. Stroke 1975; 6:318-320.
33. Blennow G, Cronqvist S, Hindfelt B, Nilsson O. On cerebral infarction in childhood and adolescence. Acta Paediatr Scand 1978; 67:469-475.
34. Giroud M, Lemesle M, Madinier G, Manceau E, Osseby GV, Dumas R. Stroke in children under 16 years of age. Clinical and etiological difference with adults. Acta Neurol Scand 1997; 96:401-406.
35. Scheffner D, Willie L. Acute infantile hemiplegia due to obstruction of intracranial arterial vessels. Neuropadiatrie 1973; 4:7-19.
36. American Academy of Pediatrics. National cholesterol education program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992; 89(3 Pt 2):525-584.
37. Williams CL, Hayman LL, Daniels SR etal. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2002; 106:143-160.
38. Nowak-Gottl U, Junker R, Hartmeier M etal. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999; 100:743-748.
39. Krawczyk M, Czarniak P, Szczesniak P etal. The prevalence of risk factors for atherosclerosis among middle school students in Sopot, Poland: results of the SOPKARD 15 programme. Kardiol Pol 2011; 69:540-545.
40. Magkos F, Manios Y, Christakis G, Kafatos AG. Secular trends in cardiovascular risk factors among school-aged boys from Crete, Greece, 1982-2002. Eur J Clin Nutr 2005; 59:1-7.
41. CDC. Prevalence of abnormal lipid levels among youths - United States, 1999-2006. MMWR Morb Mortal Wkly Rep 2010; 59:29-33.
42. Simma B, Martin G, Muller T, Huemer M. Risk factors for pediatric stroke: consequences for therapy and quality of life. Pediatr Neurol 2007; 37:121-126.
43. Nowak-Gottl U, Debus O, Findeisen M etal. Lipoprotein (a): its role in childhood thromboembolism. Pediatrics 1997; 99:E11.
44. Nowak-Gottl U, Strater R, Heinecke A etal. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999; 94:3678-3682.
45. Strater R, Vielhaber H, Kassenbohmer R, von Kries R, Gobel U, Nowak-Gottl U. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr 1999; 158(Suppl 3):S122-125.
46. Nowak-Gottl U, Langer C, Bergs S, Thedieck S, Strater R, Stoll M. Genetics of hemostasis: differential effects of heritability and household components influencing lipid concentrations and clotting factor levels in 282 pediatric stroke families. Environ Health Perspect 2008; 116:839-843.
47. Beheiri A, Langer C, During C, Krumpel A, Thedieck S, Nowak-Gottl U. Role of elevated alpha2-macroglobulin revisited: results of a case-control study in children with symptomatic thromboembolism. J Thromb Haemost 2007; 5:1179-1184.
48. Teber S, Deda G, Akar N, Soylu K. Lipoprotein (a) levels in childhood arterial ischemic stroke. Clin Appl Thromb Hemost 2010; 16:214-217.
49. Lynch JK, Han CJ, Nee LE, Nelson KB. Prothrombotic factors in children with stroke or porencephaly. Pediatrics 2005; 116:447-453.
50. Barreirinho S, Ferro A, Santos M etal. Inherited and acquired risk factors and their combined effects in pediatric stroke. Pediatr Neurol 2003; 28:134-138.
51. Normann S, de Veber G, Fobker M etal. Role of endogenous testosterone concentration in pediatric stroke. Ann Neurol 2009; 66:754-758.
52. Daniels SR, Bates S, Lukin RR, Benton C, Third J, Glueck CJ. Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke. Stroke 1982; 13:360-365.
53. Glueck CJ, Daniels SR, Bates S, Benton C, Tracy T, Third JL. Pediatric victims of unexplained stroke and their families: familial lipid and lipoprotein abnormalities. Pediatrics 1982; 69:308-316.
54. Balcerzyk A, Zak I, Niemiec P etal. APOE gene epsilon polymorphism does not determine predisposition to ischemic stroke in children. Pediatr Neurol 2010; 43:25-28.
55. Kopyta I, Sarecka-Hujar B, Emich-Widera E, Marszal E, Zak I. Association between lipids and fibrinogen levels and ischemic stroke in the population of the Polish children with arteriopathy and cardiac disorders. Wiad Lek 2010; 63:17-23.
56. Abram HS, Knepper LE, Warty VS, Painter MJ. Natural history, prognosis, and lipid abnormalities of idiopathic ischemic childhood stroke. J Child Neurol 1996; 11:276-282.
57. Kurnik K, Kosch A, Strater R, Schobess R, Heller C, Nowak-Gottl U. Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke: a prospective follow-up study. Stroke 2003; 34:2887-2892.
58. Skinner AC, Steiner MJ, Chung AE, Perrin EM. Cholesterol curves to identify population norms by age and sex in healthy weight children. Clin Pediatr (Phila) 2012; 51:233-237.
59. Brotons C, Ribera A, Perich RM etal. Worldwide distribution of blood lipids and lipoproteins in childhood and adolescence: a review study. Atherosclerosis 1998; 139:1-9.
60. Ahnve S, Angelin B, Edhag O, Berglund L. Early determination of serum lipids and apolipoproteins in acute myocardial infarction: possibility for immediate intervention. J Intern Med 1989; 226:297-301.
61. Fyfe T, Baxter RH, Cochran KM, Booth EM. Plasma-lipid changes after myocardial infarction. Lancet 1971; 2:997-1001.
62. Stubbe I, Gustafson A, Nilsson-Ehle P. Alterations in plasma proteins and lipoproteins in acute myocardial infarction: effects on activation of lipoprotein lipase. Scand J Clin Lab Invest 1982; 42:437-444.
63. Andreassen AK, Berg K, Torsvik H. Changes in Lp(a) lipoprotein and other plasma proteins during acute myocardial infarction. Clin Genet 1994; 46:410-416.
64. Kargman DE, Tuck C, Berglund L etal. Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. Atherosclerosis 1998; 139:391-399.
65. Rodan L, McCrindle BW, Manlhiot C etal. Stroke recurrence in children with congenital heart disease. Ann Neurol 2012; 72:103-111.
66. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128(Suppl 5):S213-256.
67. Roach ES, Golomb MR, Adams R etal. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008; 39:2644-2691.
68. Carlson LA, Hamsten A, Asplund A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med 1989; 226:271-276.
69. Boden WE, Probstfield JL, Anderson T etal. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011; 365:2255-2267.
70. Nicholls SJ. Is niacin ineffective? Or did AIM-HIGH miss its target? Cleve Clin J Med 2012; 79:38-43.
71. Bernard TJ, Manco-Johnson MJ, Lo W etal. Towards a consensus-based classification of childhood arterial ischemic stroke. Stroke 2012; 43:371-377.
72. Wiegman A, Hutten BA, de Groot E etal. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 2004; 292:331-337.
73. van der Graaf A, Nierman MC, Firth JC, Wolmarans KH, Marais AD, de Groot E. Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia. Acta Paediatr 2006; 95:1461-1466.
74. Gandelman K, Glue P, Laskey R, Jones J, LaBadie R, Ose L. An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia. Pediatr Cardiol 2011; 32:433-441.